Prime Medicine, Inc.
Ticker: 1894562
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q3 FY2024 | Q1 FY2024 |
|---|---|---|---|---|---|
| INCOME | |||||
| Revenue | 1.23+9.8% | 1.12-22.8% | 1.45+590.5% | 0.21-64.4% | 0.59 |
| Total Income | 1.23+9.8% | 1.12-22.8% | 1.45+590.5% | 0.21-64.4% | 0.59 |
| EXPENSES | |||||
| Expenditure | 55.20+1.3% | 54.49+1.2% | 53.85-1.1% | 54.44+11.3% | 48.93 |
| Tax | — | 0.00 | 0.00 | 0.00-100.0% | 0.13 |
| PROFIT | |||||
| Net Profit | -50.58+3.8% | -52.59-1.3% | -51.89+1.2% | -52.52-14.8% | -45.76 |
| KEY METRICS | |||||
| OPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| NPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| EPS | -0.32+22.0% | -0.41-2.5% | -0.40+9.1% | -0.44+0.0% | -0.44 |
Corporate Events
Board MeetingPRME
20265Jun
Board Meeting
2026 Annual Meeting of Stockholders to elect Class I Directo…
SEC Filing ↗